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Abstract
Background: Limbal stem cells (LSC) sustain the corneal integrity and homeostasis. LSC deficiency (LSCD) leads to
loss of corneal transparency and blindness. A clinical approach to treat unilateral LSCD comprises autologous
cultured limbal epithelial stem cell transplantation (CLET). CLET uses xenobiotic culture systems with potential
zoonotic transmission risks, and regulatory guidelines make necessary to find xenofree alternatives.
Methods: We compared two xenofree clinical grade media and two feeder layers. We used CnT07, a defined
commercial medium for keratinocytes, and a modified xenofree supplemented hormonal epithelial medium with
human serum (XSHEM). Optimal formulation was used to compare two feeder layers: the gold standard 3T3 murine
fibroblasts and human processed lipoaspirate cells (PLA). We tested the expressions of ΔNp63α and cytokeratin 3
and 12 by qPCR and immunofluorescence. Morphology, viability, clonogenicity, proliferation, and cell growth assays
were carried out. We also evaluated interleukin 6 (IL-6) and stromal-derived factor 1 (SDF-1) by qPCR and ELISA.
Results: XSHEM maintained better LSC culture viability and morphology than CnT07. Irradiated PLA feeder cells
improved the undifferentiated state of LSC and enhanced their growth and clonogenicity stimulating IL-6 secretion
and SDF-1 expression, as well as increased proliferation and cell growth when compared with irradiated 3T3 feeder
cells.
Conclusions: The combination of XSHEM and PLA feeder cells efficiently sustained LSC xenofree cultures for clinical
application. Moreover, PLA feeder layers were able to improve the LSC potential characteristics. Our results would
have direct clinical application in CLET for advanced therapy.
Keywords: Cultured limbal stem cells transplantation, XSHEM, CnT07, Processed lipoaspirate cells, 3T3, Clinical
grade, Limbal stem cells deficiency
Background
The transparency and the integrity of the cornea are
maintained by a subset of stem cells located at the epi-
thelial basal layer of the limbus, an anatomic circumfer-
ential area that separates the transparent cornea from
the conjunctiva [1]. These stem cells are called limbal
stem cells (LSC), and they are defined by their small size,
high nucleus-to-cytoplasm ratio [1, 2], and positivity for
the putative stemness marker ΔNp63α [2, 3] as well as
negativity for corneal epithelial differentiation markers
cytokeratin (CK) 12 and CK3 [2]. The loss of LSC pro-
duces new vessel formation, corneal conjunctivalization,
and scarring, leading to corneal blindness [4]. Limbal
stem cell deficiency (LSCD) can be caused by chemical,
traumatic, and infectious insults and also by genetic eti-
ologies [4]. Its prevalence is increasing, due to the use of
corrosive cleaners in the household field [5]. Approxi-
mately, LSCD affects approximately 10 million people
worldwide [6, 7].
Although the technique for the treatment of unilateral
LSCD has evolved with time, the current gold standard
treatment for unilateral LSCD is cultured limbal epithelial
stem cell transplantation (CLET) [8]. For CLET, the LSC
can be cultured by explant or cell suspension systems [9].
In the first system, a small biopsy of the healthy limbus is
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seeded on amniotic membrane. The cells grow, and the
sheet is transplanted onto the damaged eye. In the cell
suspension approach, LSC obtained from a minimally inva-
sive limbal biopsy are enzymatically disaggregated and
ex vivo expanded on an inactivated feeder layer of 3T3
murine fibroblasts until sub-confluence. Then, the cells are
detached and seeded on a biocompatible carrier for trans-
plantation [8, 9]. This approach is more advantageous than
explant systems, since it reduces the risk of contamination
of the culture by other limbal cells (such as stromal fibro-
blasts) [10] and increases the amount of cells that can be
obtained due to higher proliferation rates [11–13]. More-
over, the cell suspension cultures are an optimized option
since they are more enriched in stem cell progenies than
explant culture methods [10, 12, 13] leading to improved
outcomes [14].
Since the first use of CLET for human LSCD treat-
ment in 1997 [15], xeno-products have been used for
the ex vivo expansion of LSC both in explant and cell
suspension systems [16]. However, European regulatory
guidelines [17, 18] for the safety and quality of human
tissues and cells encourage the implementation of standard
operating procedures to prevent the use of xenogeneic
compounds and the potential associated contamination. Al-
though the use of xeno-products supposes a risk for human
health by virus, prions, and zoonoses transmission [19], lit-
tle research has been made to avoid xenobiotics during
LSC culture in suspension systems [20–22]. Besides, trad-
itional LSC media for clinical application contain cholera
toxin [15, 23], increasing the risk of disease transmission.
So, substitution of the LSC culture medium containing
serum and xenobiotics from animal origin, along with the
replacement of the feeder layer of murine 3T3 fibroblasts
by xenofree alternatives, is of utmost significance.
To study clinical grade xenofree alternatives that could
serve to maintain LSC cultures for cell therapy in
humans, we tested two xenofree media and two feeder
layer approaches. We compared a defined commercial
medium, designed to sustain keratinocyte growth, with a
supplemented hormonal epithelial medium complemen-
ted with human serum (XSHEM). Then, we performed a
comparison between the gold standard murine 3T3 fi-
broblasts [16] and human processed lipoaspirate cells
(PLA) as a feeder layer for LSC culture growth. Our re-
sults propose a clinical grade alternative free of xenobi-
otics to sustain optimal LSC culture growth with direct
clinical application for advanced therapy.
Materials and methods
Cell culture of feeder layers
Murine 3T3 Swiss Albino fibroblasts were obtained from
Kerafast (3T3-J2, EF3003). Cells were cultured with DMEM
4.5 g/l (Thermo Scientific, MA, USA) supplemented with
10% FCS and 1% antibiotics. Human processed lipoaspirate
cells (PLA) from fresh human lipoaspirates were collected
from healthy donors, during plastic liposuction procedures,
in planned lipoaspiration surgeries. PLA were obtained by
stromal vascular fraction isolation, and cultured and charac-
terized as previously described [24]. PLA cells accomplished
the criteria for mesenchymal stem cell characterization (data
not shown) [25]. Then, both 3T3 and PLA cells were inacti-
vated by irradiation with 6000 rads. After this, cells were
plated onto culture dishes at 2 × 104 cells/cm2 for feeder-
layer use or downstream experiments.
Human LSC and corneal epithelial cells
Cadaveric adult human limbal tissues from six different
donors were obtained from the Barcelona Tissue Bank
(BTB-BST, Barcelona, Spain; http://www.bancsang.net/
en_index/). LSC were isolated as previously described
[26, 27]. LSC from each donor were equally divided and
cultured until sub-confluence with xenofree supple-
mented hormonal epithelial media (XSHEM) or CnT07
medium (CellnTec, Bern, Switzerland) on 3T3 or PLA
feeder layers that were seeded 24 h before. XSHEM com-
position consisted of the following: Dulbecco’s modified
Eagle’s medium/Ham’s and F-12 (2:1 vol:vol) (DMEM/
F12; Invitrogen, Carlsbad, CA) supplemented with 2mM
L-glutamine (Lonza, Verviers, Belgium), 5 μg/ml human
insulin (Sigma Aldrich, Munich, Germany), 10 ng/ml hu-
man epidermal growth factor (hEGF, Sigma-Aldrich),
0.5% dimethyl sulfoxide (DMSO, Sigma-Aldrich), 0.4 μg/
ml hydrocortisone (Sigma-Aldrich), 2 nM triiodothyronine
(Sigma-Aldrich), 0.18mM adenine (Sigma-Aldrich), and
10% Human AB Serum (Corning, Manassas, VA). After
the isolation passage, cells were used for downstream
applications. Human corneal epithelial cells (CO) were
obtained by mechanical scrapping of the central corneal
epithelium of five different donors, avoiding the perilimbal
region, and used as control for qPCR experiments.
Colony-forming assay (CFA) and doubling population
time (DPT)
For CFA determination, LSC that were previously cul-
tured on 3T3 or PLA feeder layers were seeded in 35-
mm-diameter plates and cultured for 14 days [28] with
3T3 feeder-layer support. Colonies were fixed and stained
with 0.5% crystal violet in methanol. Analysis was per-
formed according to previous criteria and presented as a
percentage after applying the previously described formula
[29]. The diameter of each colony was measured using
ImageJ software [30]. DPT was calculated as described
elsewhere [31].
Immunofluorescence (IF)
Cells of each experimental group (5 × 105) were added
to ThinPrep® PreservCyt solution (Hologic Iberia SL,
Barcelona, Spain) for fixation and preservation. Cells
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were then transferred to slides using ThinPrep 3000 pro-
cessor (Hologic), which allowed the cells to be seeded in a
single plane without forming clumps. Slides were pre-
served in methanol until use, permeabilized, blocked, and
then incubated with primary antibodies. After several
washes in 100mM PBS solution, proper secondary anti-
body was added for 60min at 37 °C in a humidified cham-
ber. The antibodies and concentrations used are detailed
in Additional file 2: Table S1. Cells were observed in an
epifluorescence microscope (BX61; Olympus R-FTL-T;
Olympus America Inc., Center Valley, PA), coupled with a
program for digital image acquisition (Olympus DP Con-
troller Program). Images were processed with ImageJ soft-
ware [30].
mRNA extraction and quantitative polymerase chain
reaction (qPCR) analysis
Total RNA was extracted from co-cultures of LSC with ei-
ther 3T3 or PLA feeder layers or from monocultures of the
feeder layers at the last day of LSC culture. The extraction
was performed using RNA Purelink Mini Kit (Ambion,
Invitrogen), following the manufacturer’s instructions. The
RNA concentration was measured using NanoDrop lite
spectrophotometer (Thermo Scientific). RNA (1 μg) was
reverse-transcribed using Superscript III (Invitrogen) ac-
cording to the manufacturer’s instructions. Then, cDNA
(1 μl) was used for qPCR in a final volume of 18 μl with
Lightcycler 480 Sybr Green I Master (Roche, Barcelona,
Spain) and a 0.2-μM primer concentration. The qPCR was
performed using Lightcycler 480 II (Roche) hardware and
software. The expression level of target genes was normal-
ized to internal 18s (rrn18s, TATAA Biocenter, Sweden)
and represented as relative expression using 2-ΔΔCt formula.
The sequences and annealing temperatures of PCR primers
are listed in Additional file 2: Table S2.
ELISA assay
Cell culture medium was recovered at every change of
medium and was centrifuged at 13,000 rpm during 5
min. Supernatants were stored at − 80 °C until analysis.
ELISA assay for interleukin-6 (IL-6) was performed with
a specific human ELISA kit for IL-6 (Biosource Europe,
Medgenix, Nivelles, Belgic) according to the manufac-
turer’s instructions.
Metabolic assay
Cell growth was tested using WST-1 assay (Abcam,
Cambridge, UK) attending the manufacturer’s recom-
mendations at every medium change. Plates were read at
450 nm with a reference wavelength of 680 nm in an ab-
sorbance plate reader (Biotek).
Viability calculation
Viability was tested using live/dead assay (Invitrogen) be-
fore and after detachment of the cultures following the
manufacturer’s instructions. Moreover, viability calcula-
tion was performed using trypan blue exclusion assay on a
Neubauer chamber after detachment of the cells with Try-
pLE Select® (Sigma-Aldrich).
Statistical analysis
Experiments were performed in triplicate. A two-tailed
Student’s t test was run, and p values < 0.05 were consid-
ered statistically significant (PRISM, version 6.0 Graph-
Pad Software, San Diego, CA). Results are presented as
the mean ± standard error (MD ± SE) or, in the case of
the qPCR analysis, mean ± standard deviation (MD ±
SD).
Results
XSHEM produced cells with LSC morphology and higher
viability
We compared the culture features and the morphology
of LSC when cultured with CnT07 and XSHEM
medium. Moreover, we determined their doubling popu-
lation time (DPT) and the viability at the end of the
culture (Fig. 1). Cells cultured in CnT07 were small and
cuboidal with a characteristic cobblestone morphology
and grew forming a single monolayer (Fig. 1d, f). Usually,
these cultures showed bigger cells with lower nucleus-to-
cytoplasm ratio, interspersed between the smaller cells
(Fig. 1h). Cells cultured with XSHEM were small and pol-
ygonal (Fig. 1e), and grew from colonies that rapidly
merged forming thicker stratifications (Fig. 1c, e, g). At the
end of the culture, before recombinant protease detach-
ment, live/dead assay showed that cells had similar viability
(Additional file 1: Figure S1). After recombinant protease
detachment, cells cultured with CnT07 presented a more
impaired viability than those in XSHEM medium, as
showed by trypan blue exclusion assay (Fig. 1a) and by live/
dead assay (Additional file 1: Figure S1). However, DPT did
not show differences between both culture media (Fig. 1b).
LSC in XSHEM and in CnT07 were positive for p63 and
negative for corneal differentiation markers
We evaluated the expression of ΔNp63α, other characteris-
tic stem cells, and corneal markers such as Bmi1, ABCG2,
CK15, CK19, PAX6, CK12, and CK3, by qPCR and im-
munofluorescence (Fig. 2). Both XSHEM and CnT07 lead
to LSC highly positive for ΔNp63α as demonstrated by im-
munofluorescence (Fig. 2d), with similar expression by
qPCR (Fig. 2b). Meanwhile, the expression of Bmi1, ABCG2,
and CK15 was higher in XSHEM (Fig. 2c). The mRNA ex-
pression of CK3, CK12, and PAX6 was negligible when
compared to corneal epithelial cells (CO); the positive con-
trol obtained directly scrapped form central corneas (Fig. 2a,
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c). LSC cultured in CnT07 showed higher mRNA expres-
sion for CK3 and PAX6 than those cultured in XSHEM
(Fig. 2a). However, both cultures were negative for CK3 and
CK12 as assayed by immunofluorescence (Fig. 2d).
PLA increased the clonogenicity and growth of LSC
Taking into account previous results, XSHEM medium
was selected to assay the potential of PLA as feeder
layers for LSC. To this end, we compared LSC cultured
Fig. 1 Comparison of the DPT, viability, and morphology of LSC grown with XSHEM or CnT07. a Evaluation of the viability by trypan blue
exclusion assay. Cell viability was higher with XSHEM medium after cell detachment. b DPT did not show differences between both media. c
Morphology of a starting culture of LSC cultured in XSHEM, corresponding to one clone in expansion. d Morphology of a starting culture of LSC
cultured in CnT07. No clones could be observed. e Morphology of LSC cultured in XSHEM. Cells were small and polygonal. f Morphology of LSC
cultured in CnT07. Cells had a cobblestone morphology, but differentiated cells could be observed (arrows). g XSHEM cultures showed
stratifications as clones grew. h CnT07 cultures only grew forming monolayers and did not form any stratification. Results are presented as
mean ± SE from three independent experiments. Statistical analysis was performed using two-tailed Student’s t tests (***p < 0.001). DPT, doubling
population time; LSC, limbal stem cells; XSHEM, xenofree supplemented hormonal medium. Bar = 100 μm for c to g. Bar = 50 μm for h
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either with PLA or with 3T3, the gold standard feeder
layer for CLET, for clonogenicity, DPT, and cell growth
using WST-1 assay (Fig. 3). The LSC cultured on PLA
feeder layer (LSC-PLA) took less time to reach sub-
confluence than the LSC grown on 3T3 (LSC-3T3).
Therefore, the DPTs were lower in these LSC (Fig. 3c),
indicating faster cell growth. In fact, cell growth of LSC-
PLA increased with culture time up to reaching sub-
Fig. 2 Expression of stemness and differentiation markers in LSC grown in XSHEM and CnT07. a Analysis of the mRNA expression levels for
corneal differentiation markers CK3 and CK12. Their expression was minimal when compared with CO, although LSC cultured in CnT07 expressed
more CK3 than those cultured in XSHEM. b Analysis of the mRNA expression levels for the stemness marker ΔNp63α did not show differences
between LSC cultured in XSHEM or CnT07. c Analysis of the mRNA expression levels for Bmi1, ABCG2, CK19, CK15, and PAX6. d
Immunofluorescence for p63, CK3, and CK12. Cultures showed a broad positivity for p63, while were widely negative for CK3 and CK12. Results
are presented as mean ± SE from three independent experiments. Statistical analysis was performed using two-tailed Student’s t tests (*p < 0.05;
***p < 0.001; n.s, not significant). CK, cytokeratin; CO, human corneal epithelial cells; XSHEM, xenofree supplemented hormonal medium. Bar =
10 μm for p63. Bar = 25 μm for CK3 and CK12
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confluence at day 6 (D6). Instead, co-cultures of LSC-
3T3 showed decreased cell growth at day 4 of culture
(D4), and then, cell growth increased until the end of
the culture at day 10 (D10) (Fig. 3a). Accordingly, LSC-
PLA presented more ki67-positive cells at the end of the
culture (Additional file 1: Figure S2), showed higher clo-
nogenic capacity, and exhibited clones with bigger diam-
eter (Fig. 3d, f). Moreover, viability tests by trypan blue
assay and live/dead assay did not show differences after
the protease detachment of the cultures (Fig. 3b and
Additional file 1: Figure S1). No obvious cell death could
be observed at the end of the cultures as well.
LSC-PLA expressed more IL-6 and SDF-1 than LSC-3T3
To elucidate if the possible mechanism through PLA
could favor the improvement of clonogenicity and cell
growth of LSC, we analyzed the expression of IL-6 and
SDF-1 (Fig. 4). The secretion of IL-6 was evaluated by spe-
cific human IL-6 ELISA assay at different culture time
points in the supernatants of co-cultures and in the PLA
and 3T3 cultures (Fig. 4a). Interestingly, at the first 24 h
(D1), PLA feeders secreted their highest amount of IL-6.
At day 2 (D2), the IL-6 levels decayed in these PLA cul-
tures. At this time point, the initiated co-cultures of LSC-
PLA started to increase their expression of IL-6. These
levels of IL-6 secretion continued to increase remarkably
until the end of the culture, at day 7 (D7). Conversely,
PLA cultures retained lower levels of IL-6 until the end.
LSC-3T3 secreted lower levels of IL-6 in comparison with
LSC-PLA. IL-6 secretion by LSC-3T3 reached their max-
imum secretion at day 7 (D7), 2 days before reaching sub-
confluence. As expected, due to the specificity for human
IL-6, no IL-6 could be detected in the 3T3 cultures. So, a
qPCR was run with specific primers for mouse IL-6
mRNA. The results showed that 3T3 cells expressed sig-
nificantly lower mRNA expression than PLA (Fig. 3b). In
addition, qPCR results for IL-6 confirmed ELISA data re-
garding LSC-PLA and LSC-3T3 co-cultures.
Fig. 3 Cell growth, viability, and clonogenicity of the LSC cultured on murine 3T3 or human PLA feeder layers. a Cell growth evaluated by WST-1
was higher in LSC grown on PLA feeder layers during culture. b Evaluation of the LSC viability by trypan blue exclusion assay did not show
differences after cell detachment. c DPT was higher in LSC cultured on PLA feeder cells. d Clonogenicity was increased in LSC cultured on PLA
feeder cells (n = 6). e The colony diameters were larger in LSC cultured on PLA feeder cells. f CFA results are presented as mean ± SE from at least
three independent experiments. Statistical analysis was performed using two-tailed Student’s t tests (**p < 0.01; ***p < 0.001). CFA, colony forming
assay; D, day; DPT, doubling population time; LSC, limbal stem cells; LSC-3T3, co-cultures of LSC with 3T3 feeder layers; LSC-PLA, co-cultures of
LSC with PLA feeder layers; PLA, processed lipoaspirate cells
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When assayed by qPCR, monocultures of PLA showed
higher expression of SDF-1 than monocultures of 3T3
cells (Fig. 3c). Accordingly, the co-cultures of LSC and
PLA showed a markedly increased expression of SDF-1
than the co-cultures of LSC and 3T3.
Both PLA and 3T3 feeder generated cells with LSC
characteristics
Both LSC co-cultured on PLA and on 3T3 feeder layers
were analyzed for their morphology and the expression
of ΔNp63α, Bmi1, ABCG2, CK15, CK19, PAX6, CK3,
and CK12 by qPCR and immunofluorescence. There
were no differences regarding the morphology of LSC in
both co-culture approaches; they were smaller, expanded
from clones, and grew showing stratifications, until
reaching sub-confluence (Fig. 5). Moreover, there were
also no differences in the percentage of p63-positive cells
in co-cultures, showing a broad positivity for ΔNp63α,
as assayed by immunofluorescence (Fig. 6b, c). Results
from qPCR corroborated similar mRNA expression for
ΔNp63α between conditions (Fig. 6a). However, in-
creased mRNA expression for Bmi1 and CK15 was de-
tected in LSC-PLA without significant differences
regarding ABCG2, CK19, and PAX6 expression (Fig. 7a).
Negativity for CK3 and CK12 was observed by immuno-
fluorescence and qPCR in LSC-PLA or LSC-3T3, and
lower mRNA expression of PAX6 was detected in com-
parison with CO (Fig. 7a, b).
Discussion
The search for clinical grade xenofree alternatives to
culture LSC for advanced therapy is a need. Here, we
demonstrated that LSC maintained an undifferentiated
state and an adequate morphology, and improved its
doubling population time and stemness when cultured
in XSHEM on PLA feeder layer, without the interven-
tion of any xenobiotic.
The maintenance of the size and the morphology of
LSC have deep implications in their characterization
[1, 2, 32]. LSC cultured with XSHEM media were
smaller, with higher nucleus-to-cytoplasm ratio, and
the cultures showed stratifications. Although stratifi-
cation in LSC cultures is prevented in cell therapy be-
cause they can induce cell differentiation by cell
confluence, this is a well-known trait of LSC cultures
and an indication of the quality of the culture [33].
The cultures of CnT07 grew in monolayers, had an
impaired viability after detachment, and had lower ex-
pression of progenitor markers Bmi1 and ABCG2.
This pointed out that XSHEM maintains better LSC
culture characteristics than CnT07, although there
were no differences in the expression of the putative
stemness marker p63 by qPCR and immunofluores-
cence. In addition, both medium conditions prevented
the expression of corneal differentiation epithelial
markers CK3 and CK12. Our results also support pre-
vious data showing that LSC express lower levels of
Fig. 4 Expression of IL-6 and SDF-1. a ELISA assay detected
increased expression of human IL-6 during the co-cultures of LSC
with PLA. PLA monocultures also secreted higher levels of IL-6
during the first day of seeding. b Analysis of mRNA expression levels
of IL-6 in 3T3 and PLA monocultures, and in LSC co-cultures with
both feeder layers. c Analysis of mRNA expression levels of SDF-1 in
3T3 and PLA monocultures, and in LSC co-cultures with both feeder
layers. Statistical analysis was performed using two-tailed Student’s t
tests (**p < 0.01 compared to LSC-3T3; ***p < 0.001 compared to
LSC-3T3; &p < 0.001 compared to PLA; %p < 0.01 compared to 3T3).
D, day; IL-6, interleukin-6; LSC, limbal stem cells; LSC-3T3, co-cultures
of LSC with 3T3 feeder layers; LSC-PLA, co-cultures of LSC with PLA
feeder layers; PLA, processed lipoaspirate cells; SDF-1, stromal
derived factor
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PAX6 when compared to more differentiated progen-
ies [34]. Moreover, our results are consistent with
previous research showing that serum supplemented
media maintain better survival and enrichment of LSC
than commercial defined keratinocyte media [35].
The use of non-defined media has drawbacks, such as
batch to batch serum variations [36]; however, “in
house” formulations allow independence of commercial
companies overcoming the need of further GMP valida-
tions if the product became discontinued. Another draw-
back of a non-defined medium is the potential risk of
disease transmission [36]. However, this risk can also be
managed effectively by the application of the European
regulatory controls [17, 18]. Thus, microbiologic purity
of the media can be tested and further validated to avoid
disease transmission and assure an aseptic manufactur-
ing process [37].
LSC growth under an undifferentiated state is proved
with defined media only when supplemented with either
human serum or synthetic supplements [20, 38]. Here,
we showed that our defined medium without serum sup-
plementation hinders the viability of LSC, making the
culture less cost-effective. One explanation for the viabil-
ity loss could be that the recombinant protease used for
cell detachment was not completely inhibited by defined
media, which usually contain low concentration of pro-
teins and other elements such as calcium. Then, the cell
viability loss in CLET could impair the outcomes of the
transplantation by decreasing the survival of undifferen-
tiated progenies [14]. For all these reasons, XSHEM
medium represented a better alternative to culture LSC
for human application and was chosen to test different
feeder layers.
LSC cultures obtained in suspension systems directly
on amniotic membrane without feeder layers in xenofree
conditions produce grafts enriched in differentiated cells,
positive for CK3 and CK12, indicating the loss of stem
cell progenies [21]. This highlights the importance of the
feeder layer to culture LSC. Although 3T3 feeder cells
are necessary to maintain better cumulative LSC cell
numbers even with xenofree medium [20], the risk of
murine fibroblast use is the potential inflammatory re-
sponses against the graft generated by the presence of
xeno-antigens in LSC transplant [39]. This would impair
the results of the transplantation since any inflammatory
reaction could lead to detrimental outcomes after graft-
ing [40–43]. Avoiding this risk, one study changed the
3T3 feeder cells by human embryonic fibroblast cell line
[22], demonstrating the same feasibility to support LSC
cell growth. Since the use of human embryonic cells en-
tails ethical implications and is related to teratogenic
risks [44], somatic stem cell lines, such as PLA [45, 46],
may be more advantageous for clinical applications. Hu-
man PLA are easy to obtain and isolate [45] and could
be used for allogenic or autologous feeder layer pur-
poses. Allogenic PLA feeder cells could be well charac-
terized following international recommendations [25],
screened for paracrine secretion, optimized to sustain
LSC growth, and GMP-banked [46–48]. Moreover, PLA
cells do not express HLA DRII [49] being invisible to
the immune system and avoiding rejection in allogenic
clinic application [50].
Successful clinical outcomes with CLET approach are re-
lated to the presence of undifferentiated progenies [14].
Since our culture system with XSHEM medium and PLA
feeder layer generates undifferentiated LSC with higher clo-
nogenic potential, expressing more Bmi1, highly positive for
p63 and negative for the expression of CK3 and CK12, it is
likely to provide better outcomes in clinical transplantation.
Moreover, we demonstrated that PLA feeders induced faster
Fig. 5 Morphology of LSC cultured on 3T3 or PLA feeder layers. a, b LSC cultured either on PLA or on 3T3 formed clones when the culture
started. c, d In both cultures, cells were small and polygonal. e–f Clones of both cultures grew, merged, and formed stratifications. LSC, limbal
stem cells; LSC-3T3, co-cultures of LSC with 3T3 feeder layers; LSC-PLA, co-cultures of LSC with PLA feeder layers; PLA, processed lipoaspirate cells.
Bar = 50 μm for a and b. Bar = 100 for c to f
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proliferation and cell growth on LSC, so the cultures were
more cost-effective. Moreover, the viability of LSC cultured
on both feeders after detachment was similar. This fact
makes sense, since both cultures used the same medium
and the protease could be inhibited with the same efficacy.
Finally, there is a close interaction between LSC and their
microenvironment, such as their neighboring cells and
extracellular matrix, which regulate their proliferation and
differentiation in the limbal niche [51]. When LSC are co-
isolated with limbal stromal niche cells, the LSC proliferate
Fig. 6 Expression of stemness and differentiation markers in LSC cultured with PLA and 3T3 feeder layers. a Analysis of the mRNA expression
levels for stemness marker ΔNp63α. b The number (%) of p63-positive LSC cultured on PLA or 3T3 feeder layers did not show
differences (n = 100). c Immunofluorescence quantification of p63-positive LSC cultured on PLA or 3T3 feeder layers did not show differences (n= 100).
Immunofluorescence showing broad positivity for p63. Results are presented as mean ± SE from three independent experiments. Statistical analysis was
performed using two-tailed Student’s t tests (*p< 0.05; **p< 0.01; ***p< 0.001; ns, not significant). CO, corneal epithelial cells; LSC, limbal stem cells; LSC-
3T3, co-cultures of LSC with 3T3 feeder layers; LSC-PLA, co-cultures of LSC with PLA feeder layers; PLA, processed lipoaspirate cells. Bar = 50 μm
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faster and form more clones through the expression of SDF-
1 [52], highlighting the importance of the communication
between LSC and the stromal cells for their proliferation
and maintenance. Moreover, IL-6 is secreted by limbal and
stromal cells which act as a mediator between both cell pop-
ulations, increasing the clonogenic potential and maintain-
ing an undifferentiated state of LSC in in vitro culture
systems [53]. Here, we also demonstrated that co-cultures
with PLA induced more secretion of IL-6 and SDF-1, than
co-cultures with 3T3, explaining the higher clonogenic cap-
ability, and the faster proliferation and cell growth. Human
PLA secreted high amounts of IL-6 in the first 24 h of seed-
ing, and its secretion could possibly influence the fate of
LSC culture. In addition, it is well known that murine IL-6
does not have effect on human cells due to conformational
differences within the IL-6 molecules [54]. This fact also
supports the reasoning of using feeder layers from human
origin to avoid species-specific effects.
Conclusions
In summary, we demonstrated that the substitution of
xenobiotics by human-derived alternatives is a feasible
Fig. 7 Expression of stemness and differentiation markers in LSC cultured with PLA and 3T3 feeder layers. a Analysis of the mRNA expression
levels for CK3 and CK12 (corneal epithelial differentiation markers), and Bmi1, ABCG2, CK19, CK15 (putative LSC markers), and PAX6. There was
minimal differences between LSC cultured on PLA or 3T3 feeder layers. b Immunofluorescence negative for CK12 and CK3. Results are presented
as mean ± SE from three independent experiments. Statistical analysis was performed using two-tailed Student’s t tests (*p < 0.05; **p < 0.01;
***p < 0.001; ns, not significant). CK, cytokeratin; CO, corneal epithelial cells; LSC, limbal stem cells; LSC-3T3, co-cultures of LSC with 3T3 feeder
layers; LSC-PLA, co-cultures of LSC with PLA feeder layers; PLA, processed lipoaspirate cells. Bar = 25 μm
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clinical grade xenofree option for LSC cultures in ad-
vanced therapy for ocular surface regeneration. The use of
XSHEM medium combined with PLA feeder layers not
only maintained LSC characteristics but also improved the
LSC potential. This approach will have a direct clinical ap-
plication in cell therapy for LSCD treatment.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13287-019-1501-9.
Additional file 1: Figure S1. Live/dead assay for LSC cultured in all
conditions before and after protease detachment. No obvious cell death
could be observed at the end of the cultures. After detachment, cultures
with Cnt07 medium showed impaired viability. Both conditions cultured
with XSHEM, LSC-3T3 and LSC-PLA, did not showed differences in
viability. Results are presented as mean ± SE from 3 independent
experiments. LSC, limbal stem cells; LSC-3T3, co-cultures of LSC with 3T3
feeder layers; LSC-PLA, co-cultures of LSC with PLA feeder layers; PLA,
processed lipoaspirate cells. Bar = 100 μm. Figure S2.
Immunofluorescence for ki67 in LSC-3T3 and LSC-PLA. LSC-PLA showed
higher percentage of ki67-positive cells than LSC-3T3 (n = 300). Results
are presented as mean ± SE from 3 independent experiments. Statistical
analysis was performed using two-tailed Student’s t-tests (*** p < 0.001).
LSC, limbal stem cells; LSC-3T3, co-cultures of LSC with 3T3 feeder layers;
LSC-PLA, co-cultures of LSC with PLA feeder layers; PLA, processed
lipoaspirate cells. Bar = 25 μm.
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